Good Health Can’t Wait, Says Dr. Reddy’s
Dr. Reddy’s launches new patient-centric branding at CPhI.
Dr. Reddy’s Laboratories is launching its new visual identity and branding rooted in the belief that “good health can’t wait” at CPhI Worldwide 2015. The purpose of the rebranding was to communicate the company’s transformation from an API manufacturer into a patient-centric multinational pharma player. Dr. Reddy’s is seeking to accelerate access to affordable and innovative medicines for people in need.
Medicines have a key role in enabling good health and improving quality of life. Dr. Reddy’s new branding and heart logo reflect this belief and reinforce the company’s pledge to provide tomorrow’s healthcare solutions today.
Dr. Reddy’s Active Ingredients and Custom Pharma Services (CPS) arms support global pharma companies in their quest to accelerate delivery of medicinal therapies. CPS offers manufacturing services and solutions for starting materials, intermediates, active ingredients, and finished dosage form. Partners have access to the company’s expertise and technologies (e.g., peptides, chirals, HPAPIs, steroids, activated mPEGs) as well as a global delivery network and intermediate and API portfolio.
Source: Dr. Reddy’s, Booth 6D30
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
